Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy

Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy Bart»omiej Tomasik, MD, PhD,*,y,z Anna Papis-Ubych, MD, Konrad Stawiski, MD,* Jacek Fijuth, MD, PhD, Piotr Kędzierawski, MD, PhD,{,# Jacek Sadowski, MD,{ Rafa» Stando, MD,{ Robert Bibik, MD, PhD,** oukasz Graczyk, MD,** Tomasz Latusek, MD, PhD,yy Tomasz Rutkowski, MD, PhD,zz and Wojciech Fendler, MD, PhD*,z Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland; yPostgraduate School of Molecular Medicine, Medical University of Warsaw, Poland; zDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; xDepartment of Radiotherapy, N. Copernicus Memorial Regional Specialist Hospital, Lodz, Poland; Department of Radiotherapy, Medical University of Lodz, Lodz, Poland; {Radiotherapy Department, Holycross Cancer Centre, Kielce, Poland; Jan Kochanowski University, Collegium Medicum, Kielce, Poland; Department of Radiation Oncology, Oncology Center of Radom, Radom, Poland; yyRadiotherapy Department, Maria Sk»odowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland; and zzI Radiation and Clinical Oncology Department, Maria Sk»odowska-Curie National Research Institute of Oncology, Gliwice branch, Gliwice, Poland